PubMed (MeSH Keyword) for id: 25063347

Year	Number of Results
2005	6
2006	6
2007	10
2008	12
2009	11
2010	18
2011	12
2012	7
2013	5
2014	10
2015	13
2016	9
2017	11
2018	19
2019	13
2020	20
2021	16
2022	9
2023	10
2024	3

1

Mucociliary transport in cystic fibrosis.

Cicuta P. Cicuta P. Proc Natl Acad Sci U S A. 2024 Feb 27;121(9):e2400674121. doi: 10.1073/pnas.2400674121. Epub 2024 Feb 20. Proc Natl Acad Sci U S A. 2024. PMID: 38377219 Free PMC article. No abstract available.

2

Specialized proresolving mediator resolvin E1 corrects the altered cystic fibrosis nasal epithelium cilia beating dynamics.

Briottet M, Sy K, London C, Aissat A, Shum M, Escabasse V, Louis B, Urbach V. Briottet M, et al. Proc Natl Acad Sci U S A. 2024 Jan 30;121(5):e2313089121. doi: 10.1073/pnas.2313089121. Epub 2024 Jan 22. Proc Natl Acad Sci U S A. 2024. PMID: 38252817

3

The impact of Resolvin E1 on bone regeneration in critical-sized calvarial defects of rat model-A gene expression and micro-CT analysis.

Alrumaih S, Alshibani N, Alssum L, Alshehri FA, AlMayrifi MA, AlMayouf M, Alrahlah A, Bautista LSJ. Alrumaih S, et al. J Periodontal Res. 2024 Feb;59(1):195-203. doi: 10.1111/jre.13206. Epub 2023 Nov 10. J Periodontal Res. 2024. PMID: 37947141

4

RvE1 Promotes Axin2+ Cell Regeneration and Reduces Bacterial Invasion.

Wu YC, Yu N, Rivas CA, Mehrnia N, Kantarci A, Van Dyke TE. Wu YC, et al. J Dent Res. 2023 Dec;102(13):1478-1487. doi: 10.1177/00220345231197156. Epub 2023 Oct 13. J Dent Res. 2023. PMID: 37837227

5

Resolvin E1/ChemR23 Protects Against Hypertension and Vascular Remodeling in Angiotensin II-Induced Hypertensive Mice.

Zhang J, Yin Z, Xu Y, Wei C, Peng S, Zhao M, Liu J, Xu S, Pan W, Zheng Z, Liu S, Ye J, Qin JJ, Wan J, Wang M. Zhang J, et al. Hypertension. 2023 Dec;80(12):2650-2664. doi: 10.1161/HYPERTENSIONAHA.123.21348. Epub 2023 Oct 6. Hypertension. 2023. PMID: 37800344

6

Imbalanced serum levels of resolvin E1 (RvE1) and leukotriene B4 (LTB4) may contribute to the pathogenesis of atherosclerosis.

Molaie M, Lotfi R, Heidari Moghadam R, Rezaiemanesh A, Karaji AG, Salari F. Molaie M, et al. Prostaglandins Other Lipid Mediat. 2023 Dec;169:106781. doi: 10.1016/j.prostaglandins.2023.106781. Epub 2023 Sep 11. Prostaglandins Other Lipid Mediat. 2023. PMID: 37704124

7

Periodontal and cardiovascular therapies modify specialized pro-resolving lipid mediator (sPRLM) (LPXA4, PD1, RvE1, RvD1, and MaR1)-mediated pathway: the first pilot clinical study.

Güvenç KK, Fentoğlu Ö, Calapoğlu M, Aksoy F, Orhan H. Güvenç KK, et al. Clin Oral Investig. 2023 Sep;27(9):5549-5558. doi: 10.1007/s00784-023-05174-0. Epub 2023 Aug 3. Clin Oral Investig. 2023. PMID: 37535198

8

The Anti-Aggregative Potential of Resolvin E1 on Human Platelets.

Szymańska P, Luzak B, Miłowska K, Golański J. Szymańska P, et al. Molecules. 2023 Jul 11;28(14):5323. doi: 10.3390/molecules28145323. Molecules. 2023. PMID: 37513197 Free PMC article.

9

Differential effects of resolvin D1 and resolvin E1 on cementoblast function.

Bozkurt SB, Hakki SS, Kantarci A. Bozkurt SB, et al. J Periodontol. 2023 Nov;94(11):1351-1362. doi: 10.1002/JPER.22-0510. Epub 2023 Jun 15. J Periodontol. 2023. PMID: 37322861

10

Icosapent ethyl in cardiovascular prevention: Resolution of inflammation through the eicosapentaenoic acid - resolvin E1 - ChemR23 axis.

Bäck M. Bäck M. Pharmacol Ther. 2023 Jul;247:108439. doi: 10.1016/j.pharmthera.2023.108439. Epub 2023 May 16. Pharmacol Ther. 2023. PMID: 37201735 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

195 results

Results by year